Below are the most recent publications written about "Safety" by people in Profiles.
-
Renley BM, Argenyi MS, Mereish EH, Watson RJ. Experiences of stress and social safety among sexual and gender minority youth by disability status. Disabil Health J. 2024 Jul; 17(3):101614.
-
Goralnick E, Chai PR, Erickson TB. Health and Safety Threats to Ukraine From Nonconventional Weapons: A Clear and Present Danger. JAMA. 2022 12 20; 328(23):2301-2302.
-
Hill SS, Harnsberger CR, Hahn SJ, Sturrock PR, Davids JS, Alavi K, Maykel JA. Transanal Minimally Invasive Surgery: An Effective Approach for Patients Who Require Redo Pelvic Surgery for Anastomotic Failure. Dis Colon Rectum. 2021 03 01; 64(3):349-354.
-
Cravero AL, Kim NJ, Feld LD, Berry K, Rabiee A, Bazarbashi N, Bassin S, Lee TH, Moon AM, Qi X, Liang PS, Aby ES, Khan MQ, Young KJ, Patel A, Wijarnpreecha K, Kobeissy A, Hashim A, Houser A, Ioannou GN. Impact of exposure to patients with COVID-19 on residents and fellows: an international survey of 1420 trainees. Postgrad Med J. 2021 Nov; 97(1153):706-715.
-
Kimmelstiel C, Rowin EJ. Fixed, high-volume alcohol dose for septal ablation: High risk with no benefit. Catheter Cardiovasc Interv. 2020 05 01; 95(6):1219-1220.
-
Philip PA, Lacy J, Portales F, Sobrero A, Pazo-Cid R, Manzano Mozo JL, Kim EJ, Dowden S, Zakari A, Borg C, Terrebonne E, Rivera F, Sastre J, Bathini V, L?pez-Trabada D, Asselah J, Saif MW, Shiansong Li J, Ong TJ, Nydam T, Hammel P. Nab-paclitaxel plus gemcitabine in patients with locally advanced pancreatic cancer (LAPACT): a multicentre, open-label phase 2 study. Lancet Gastroenterol Hepatol. 2020 03; 5(3):285-294.
-
Stain S, Ashley S, Walsh RM. SSAT Statement of Support for Safe Work Environments. J Gastrointest Surg. 2020 Jan; 24(1):218.
-
Muni K, Kobusingye O, Mock C, Hughes JP, Hurvitz PM, Guthrie B. Motorcycle taxi programme is associated with reduced risk of road traffic crash among motorcycle taxi drivers in Kampala, Uganda. Int J Inj Contr Saf Promot. 2019 Sep; 26(3):294-301.
-
Lieberman FS, Wang M, Robins HI, Tsien CI, Curran WJ, Werner-Wasik M, Smith RP, Schultz C, Hartford AC, Zhang P, Mehta MP. Phase 2 Study of Radiation Therapy Plus Low-Dose Temozolomide Followed by Temozolomide and Irinotecan for Glioblastoma: NRG Oncology RTOG Trial 0420. Int J Radiat Oncol Biol Phys. 2019 03 15; 103(4):878-886.
-
Horan KA, Singh RS, Moeller MT, Matthews RA, Barratt CL, Jex SM, O'Brien WH. The relationship between physical work hazards and employee withdrawal: The moderating role of safety compliance. Stress Health. 2019 Feb; 35(1):81-88.